Related references
Note: Only part of the references are listed.Role of the COX2-PGE2 axis in S. pneumoniae-induced exacerbation of experimental fibrosis
Tina Bormann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2021)
Regulatory T Cells Limit Pneumococcus-Induced Exacerbation of Lung Fibrosis in Mice
Steffi Moye et al.
JOURNAL OF IMMUNOLOGY (2020)
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
Jamie L. Todd et al.
BMC PULMONARY MEDICINE (2020)
The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis
Meritxell Tort Tarres et al.
THORAX (2019)
Inhibitory effects of total ginsenoside on bleomycin-induced pulmonary fibrosis in mice
Lu Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage
Dina Hingorani et al.
PLOS ONE (2018)
Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7
J. Guiot et al.
PLOS ONE (2017)
Surfactant dysfunction during overexpression of TGF-β1 precedes profibrotic lung remodeling in vivo
Elena Lopez-Rodriguez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis
Annie Pardo et al.
RESPIRATORY RESEARCH (2016)
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
John Hutchinson et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
MMP-9 1562C>T Gene Polymorphism and Efficacy of Glucocorticoid Therapy in Idiopathic Pulmonary Fibrosis Patients
Hai-Tao Zhang et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2015)
Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin
Sarah Knippenberg et al.
THORAX (2015)
Matrix Metalloproteinase-2 Knockout and Heterozygote Mice Are Protected from Hydronephrosis and Kidney Fibrosis after Unilateral Ureteral Obstruction
Maria K. Tveitaras et al.
PLOS ONE (2015)
Matrix metalloproteinase-9 activates TGF-β and stimulates fibroblast contraction of collagen gels
Tetsu Kobayashi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Diverse functions of matrix metalloproteinases during fibrosis
Matthew Giannandrea et al.
DISEASE MODELS & MECHANISMS (2014)
Remodelling the extracellular matrix in development and disease
Caroline Bonnans et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Profibrotic Activities for Matrix Metalloproteinase-8 during Bleomycin-Mediated Lung Injury
Vanessa J. Craig et al.
JOURNAL OF IMMUNOLOGY (2013)
TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice
Kathrin Steinwede et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Involvement of matrix metalloproteinase-2 in the development of renal interstitial fibrosis in mouse obstructive nephropathy
Xuanyi Du et al.
LABORATORY INVESTIGATION (2012)
MATRIX METALLOPROTEINASE-2 OR -9 DELETIONS PROTECT AGAINST HEMORRHAGIC TRANSFORMATION DURING EARLY STAGE OF CEREBRAL ISCHEMIA AND REPERFUSION
Y. Suofu et al.
NEUROSCIENCE (2012)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice
Izumi Onozuka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Loss of Matrix Metalloproteinase-2 Amplifies Murine Toxin-Induced Liver Fibrosis by Upregulating Collagen I Expression
Brian D. Radbill et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Biological role of matrix metalloproteinases: a critical balance
S. Loeffek et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Absence of Thy-1 results in TGF-β induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts
Gustavo Ramirez et al.
LABORATORY INVESTIGATION (2011)
Idiopathic pulmonary fibrosis
Talmadge E. King et al.
LANCET (2011)
An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition
Amartya Mishra et al.
LUNG INDIA (2011)
Expression of Matrix Metalloproteases by Fibrocytes Possible Role in Migration and Homing
Carolina Garcia-de-Alba et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
MMP expression and abnormal lung permeability are important determinants of outcome in IPF
S. McKeown et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Early and Late Changes of MMP-2 and MMP-9 in Bleomycin-Induced Pulmonary Fibrosis
Ji Young Kim et al.
YONSEI MEDICAL JOURNAL (2009)
Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin
Sandra Cabrera et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology
S Chakrabarti et al.
EXPERIMENTAL LUNG RESEARCH (2005)
MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity
J Esparza et al.
FASEB JOURNAL (2004)
Regulation of matrix biology by matrix metalloproteinases
JD Mott et al.
CURRENT OPINION IN CELL BIOLOGY (2004)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
R Visse et al.
CIRCULATION RESEARCH (2003)
Matrix metalloproteinase-9 in lung remodeling
JJ Atkinson et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis
T Itoh et al.
JOURNAL OF IMMUNOLOGY (2002)
Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat
M Corbel et al.
JOURNAL OF PATHOLOGY (2001)
Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin
T Betsuyaku et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
TIMP-1,-2,-3, and-4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?
M Selman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2000)
Share Paper
